UCB, a global biopharmaceutical company, today announced the CHMP (Committee for Medicinal Products for Human Use) has issued a positive opinion for the self-administration of RYSTIGGO® ...

Researchers identified that the dominant B cell epitope of Lachnospiraceae flagellins and the utilization of the flagellin ...

In part 2 of our interview with Katie Abouzahr, MD, Johnson & Johnson Innovative Medicine, we discuss the challenge inherent ...

Immunotherapy treatment was effective at reducing attack recurrence in patients with NMOSD but was less effective for MOGAD, a study found.

A breakthrough discovery in enzyme science could revolutionize the treatment of autoimmune disorders and other diseases tied ...

Peptide antigen-associated IgG levels were significantly lower in drug-naïve patients with first episode psychosis compared to control individuals.

More often, a person will experience a sulfite sensitivity in which the body cannot tolerate sulfites. Rather than releasing IgE, the immune system will respond by releasing a different antibody known ...

Watch as the G-Girls surprise Taraji with a performance in Studio 1A. Meet the G-Girls, a high school dance team from Miami that caught Taraji P. Henson's attention on Instagram for their ...

The Motorola Moto G 5G (2023) doesn't pick up too many upgrades, but it delivers a $150 price cut that brings new value to the budget device, even if it's still not the best in its price tier.

Johnson & Johnson today announced the nipocalimab Biologics License Application (BLA) received Priority Review designation from the U.S Food and Drug Administration (FDA) for the treatment ...

The primary outcome was fold rise in antibody titers from baseline to four weeks; seroconversion was defined as a fourfold or greater rise in preF immunoglobulin G (IgG) at four weeks. Overall ...